V CompBrief BY VELARION

Chief Medical Officer · Viridian Therapeutics, Inc. (VRDN)

Radhika Tripuraneni

FY2025 is the first fiscal year CompBrief holds for Radhika Tripuraneni as a named executive officer of Viridian Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$4,080,466

2nd of 5 named executive officers at Viridian Therapeutics by FY2025 total.

5 named officers on file for Viridian Therapeutics, FY2025

See an example →

What this number hides

The filing gives the total. Viridian Therapeutics’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Viridian Therapeutics’s whole pay program stands against its peers

  • Viridian Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VRDN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 17, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-10.

Free

Get Radhika Tripuraneni’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Radhika Tripuraneni and every company like it: Velarion Intel, free for 3 days, no card →

Radhika Tripuraneni compensation by year

Viridian Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Viridian Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$430,636
Bonus$50,000
Stock awards$0
Option awards$3,341,410
Non-equity incentive$253,529
Pension and deferred compensation$0
All other$4,891
Total$4,080,466

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Viridian Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-160344, and prior-year filings.

How this page was built: the Viridian Therapeutics, Inc. filed document, accession 0001193125-26-160344. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option310,700—$15.58

Per the Outstanding Equity Awards at Fiscal Year-End table in Viridian Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

2 Form 4 lines since the FY2025 proxy (filed April 17, 2026)
current to 2026-11-10 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-14Exercise or conversion derivative—40,000$0.000
2026-08-14Exercise or conversion—40,000$13.2140,000

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Viridian Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Stephen MahoneyPresident, Chief Executive Officer$6,776,249
Radhika Tripuraneni · this pageChief Medical Officer$4,080,466
Thomas BeethamChief Operating Officer$3,761,182
Seth HarmonChief Financial Officer$2,642,779
Jennifer TousignantChief Legal Officer$2,351,915

Radhika Tripuraneni's compensation dossier, Viridian Therapeutics

You have read Radhika Tripuraneni's totals and holdings. The dossier adds each equity grant Viridian Therapeutics disclosed for Radhika Tripuraneni and Viridian Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Viridian Therapeutics compensation record

free company brief
Viridian Therapeutics, Inc. (VRDN) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within Viridian Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Viridian Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Viridian Therapeutics's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosures
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Viridian Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Radhika Tripuraneni's compensation dossier